(Q33967624)

30 July 2017

title

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles (English)

1 reference

30 July 2017

1 reference

1 reference

human papillomavirus 16

1 reference

5

Allan Hildesheim

0 references

author name string

Denise Nardelli-Haefliger

1

1 reference

30 July 2017

Daniel Wirthner

2

1 reference

30 July 2017

John T Schiller

3

1 reference

30 July 2017

Douglas R Lowy

4

1 reference

30 July 2017

Françoise Ponci

6

1 reference

30 July 2017

Pierre De Grandi

7

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Journal of the National Cancer Institute

30 July 2017

published in

1 reference

30 July 2017

volume

95

1 reference

30 July 2017

issue

15

1 reference

30 July 2017

page(s)

1128-1137

1 reference

Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

Mucosal immunity in the female genital tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

Rectal immunization for induction of specific antibody in the genital tract of women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJG018

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJG018

1 reference

release_j4a35v25qrbatblqubrhbgq3ja

30 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j4a35v25qrbatblqubrhbgq3ja

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference